All News


All series


All All News

Why the proverb, "you should never judge a man until you've walked a mile in his shoes" is true for both cancer patients and survivors.

I’m writing to say how much I missed you this Father’s Day. It’s hard to believe that it’s been eight years since I told you how much you mean to me in person. And to think you were so worried about my breast cancer recurring; the thought that your only child and mother of your granddaughters might suffer a long and painful death – as did your own mother – before you died yourself.

For many years, breast cancer survivors have focused their hope on the number five. With the help of their oncologists, they've taken a big sip of this medical Kool aid. But are we hoping in an untruth? This survivor shares her perspective.

The FDA has granted an accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or those who have relapsed after 2 or more prior lines of therapy.

Breast cancer survivor grieves the loss of her mom to metastatic breast cancer and considers how she keeps deceased loved ones in her heart.